A Novel Approach to Delayed-Start Analyses for Demonstrating Disease-Modifying Effects in Alzheimer’s Disease

Open Access

Peer-reviewed

Research Article

Hong Liu-Seifert ,

* E-mail: liu-seifert_hong@lilly.com

Affiliation Eli Lilly and Company, Indianapolis, Indiana, United States of America
⨯
Scott W. Andersen,

Affiliation Eli Lilly and Company, Indianapolis, Indiana, United States of America
⨯
Ilya Lipkovich,

Current address: Quintiles, Durham, North Carolina, United States of America

Affiliation Eli Lilly and Company, Indianapolis, Indiana, United States of America
⨯
Karen C. Holdridge,

Affiliation Eli Lilly and Company, Indianapolis, Indiana, United States of America
⨯
Eric Siemers

Affiliation Eli Lilly and Company, Indianapolis, Indiana, United States of America
⨯

Reader Comments (0)

Alzheimer's disease
Is the Subject Area "Alzheimer's disease" applicable to this article?

Thanks for your feedback.
Research errors
Is the Subject Area "Research errors" applicable to this article?

Thanks for your feedback.
Phase III clinical investigation
Is the Subject Area "Phase III clinical investigation" applicable to this article?

Thanks for your feedback.
Simulation and modeling
Is the Subject Area "Simulation and modeling" applicable to this article?

Thanks for your feedback.
Clinical trials
Is the Subject Area "Clinical trials" applicable to this article?

Thanks for your feedback.
Statistical data
Is the Subject Area "Statistical data" applicable to this article?

Thanks for your feedback.
Parkinson disease
Is the Subject Area "Parkinson disease" applicable to this article?

Thanks for your feedback.
Statistical methods
Is the Subject Area "Statistical methods" applicable to this article?

Thanks for your feedback.